Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 14, Number 12, 2008

Articles

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Factor Xa Inactivation in Acute Coronary Syndrome
pp. 1186-1190(5)
Authors: Barantke, Melanie; Bonnemeier, Hendrik

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Bridging Innate Immunity and Myocardial Ischemia/Reperfusion Injury: The Search for Therapeutic Targets
pp. 1205-1216(12)
Authors: Arslan, Fatih; de Kleijn, Dominique P.V.; Timmers, Leo; Doevendans, Pieter A.; Pasterkamp, Gerard

Favourites:
ADD

The Blockade of IL-6 Signaling in Rational Drug Design
pp. 1217-1224(8)
Authors: Adachi, Yasuo; Yoshio-Hoshino, Naoko; Nishimoto, Norihiro

Favourites:
ADD

Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human Obesity
pp. 1225-1230(6)
Authors: Heilbronn, Leonie K.; Campbell, Lesley V.

Favourites:
ADD

Structure-Based Rationale for Interleukin 5 Receptor Antagonism
pp. 1231-1239(9)
Authors: Ishino, Tetsuya; Harrington, Adrian E.; Gopi, Hosahudya; Chaiken, Irwin

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content